☰

Inna Keselman, M.D.,Ph.D. - Publications

Affiliations: 
1994-2000 biophysics Brandeis University, Waltham, MA, United States 
 2000-2008 medicine/biophysics Mount Sinai, NYU 
 2008-2009 medicine Duke Medical School, Durham, NC, United States 
 2009- neurology University of California, Los Angeles, Los Angeles, CA 
Area:
neurophysiology, biophysics, potassium channels, muscarinic receptors, phospholipids, adenosine receptors
Website:
http://neurology.ucla.edu/education/fellowships/programs/clinical-neurophysiology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Roy S, Keselman I, Nuwer M, Reider-Demer M. Fast Neuro: A Care Model to Expedite Access to Neurology Clinic. Neurology. Clinical Practice. 12: 125-130. PMID 35747888 DOI: 10.1212/CPJ.0000000000001152  0.379
2021 Stern JM, Spivak NM, Becerra SA, Kuhn TP, Korb AS, Kronemyer D, Khanlou N, Reyes SD, Monti MM, Schnakers C, Walshaw P, Keselman I, Cohen MS, Yong W, Fried I, et al. Safety of focused ultrasound neuromodulation in humans with temporal lobe epilepsy. Brain Stimulation. 14: 1022-1031. PMID 34198105 DOI: 10.1016/j.brs.2021.06.003  0.406
2018 Mathes LM, Girgis F, Shahlaie K, Kennedy JD, Seyal M, Keselman I. T03. Responsive Neurostimulation Device (RNS) vs. Multiple Hippocampal Transections (MHT) as treatments for refractory Temporal Lobe Epilepsy (TLE) – Outcomes from a single center, the University of California, Davis Medical Center (UCDMC) Clinical Neurophysiology. 129: e2. DOI: 10.1016/J.Clinph.2018.04.004  0.328
2017 Weiss SA, Asadi-Pooya AA, Vangala S, Moy S, Wyeth DH, Orosz I, Gibbs M, Schrader L, Lerner J, Cheng CK, Chang E, Rajaraman R, Keselman I, Churchman P, Bower-Baca C, et al. AR2, a novel automatic artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software. F1000research. 6: 30. PMID 28491280 DOI: 10.12688/F1000Research.10569.2  0.602
2011 Chen LL, Haneef Z, Dorsch A, Keselman I, Stern JM. Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam. Seizure. 20: 263-5. PMID 21109468 DOI: 10.1016/J.Seizure.2010.11.004  0.486
2007 Lopes CM, Remon JI, Matavel A, Sui JL, Keselman I, Medei E, Shen Y, Rosenhouse-Dantsker A, Rohacs T, Logothetis DE. Protein kinase A modulates PLC-dependent regulation and PIP2-sensitivity of K+ channels. Channels (Austin, Tex.). 1: 124-34. PMID 18690021 DOI: 10.4161/Chan.4322  0.618
2007 Keselman I, Fribourg M, Felsenfeld DP, Logothetis DE. Mechanism of PLC-mediated Kir3 current inhibition. Channels (Austin, Tex.). 1: 113-23. PMID 18690019 DOI: 10.4161/Chan.4321  0.687
2006 Ishii Y, Pirkmaier A, Alvarez JV, Frank DA, Keselman I, Logothetis D, Mandeli J, O'Connell MJ, Waxman S, Germain D. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model. Journal of the National Cancer Institute. 98: 1238-47. PMID 16954476 DOI: 10.1093/Jnci/Djj334  0.476
1998 Schopperle WM, Holmqvist MH, Zhou Y, Wang J, Wang Z, Griffith LC, Keselman I, Kusinitz F, Dagan D, Levitan IB. Slob, a novel protein that interacts with the Slowpoke calcium-dependent potassium channel. Neuron. 20: 565-73. PMID 9539129 DOI: 10.1016/S0896-6273(00)80995-2  0.499
Show low-probability matches.